Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors
Abstract
Five active metal-conjugated inhibitors (PMA, TDT, EPDTC, JMF1586 and JMF1600) bound with the 3C-like protease of severe acute respiratory syndrome (SARS)-associated coronavirus were analyzed crystallographically. The complex structures reveal two major inhibition modes: Hg2+-PMA is coordinated to C44, M49 and Y54 with a square planar geometry at the S3 pocket, whereas each Zn2+ of the four zinc-inhibitors is tetrahedrally coordinated to the H41–C145 catalytic dyad. For anti-SARS drug design, this Zn2+-centered coordination pattern would serve as a starting platform for inhibitor optimization.
Abbreviations: BABIM, bis(5-amidino-2-benzimidazolyl) methane, EPDTC, N-ethyl-N-phenyldithiocarbamic acid zinc, ESI-MS, electrospray ionization mass spectrometry, JMF1586, bis(l-aspartato-N,O) zinc(II) ethanate, JMF1600, (nitrilotriacetato-N,O) zinc(II) acetate, NMR, nuclear magnetic resonance, PMA, phenylmercuric acetate, TDT, toluene-3,4-dithiolato zinc
Keywords: SARS, Metal ion, Protease inhibitor
To access this article, please choose from the options below
PII: S0014-5793(07)01116-7
doi:10.1016/j.febslet.2007.10.048
© 2007 Federation of European Biochemical Societies
